ABSTRACT Elunetirom (ABX‐002) is a brain‐targeted, oral prodrug being developed for the adjunctive treatment of major depressive disorder and bipolar depression. The active moiety, LL‐340001, is a thyroid hormone receptor agonist with modest selectivity for beta over alpha thyroid hormone receptors. Upon entering the brain, the intended site of action,
Jason R. Harris +11 more
wiley +1 more source
Engineering human Gut-on-a-Chip culturomics for predictive pharmacomicrobiomics of first-pass metabolism. [PDF]
Nagao I, Kim HJ.
europepmc +1 more source
Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review. [PDF]
Dumitru CN +6 more
europepmc +1 more source
Integrated Chemical Profiling and Toxicological Assessment of Total Polyphenols from <i>Cydonia oblonga</i> Mill. Reveals Potential Safety Concerns Under High-Dose Exposure. [PDF]
Aikebaier A +9 more
europepmc +1 more source
Multi-Endpoint Prediction of Bioactivity and ADMET Properties Coupled with Multi-Objective Optimization in Molecular Descriptor Space for Candidate ERα Antagonists. [PDF]
Cui Y, Qiao Y, Ren H, Qiu L.
europepmc +1 more source
Case Report: When access is limited: using CYP3A4 inhibition to maintain clinical benefit from elexacaftor/tezacaftor/ivacaftor. [PDF]
Hiscock K +4 more
europepmc +1 more source
Bridging the Pregnancy Knowledge Gap: A Real-World Analysis of Medication Use and Drug-Drug Interaction Risk in Crohn's Disease and Multiple Sclerosis. [PDF]
Williams J +4 more
europepmc +1 more source

